Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 852362, 10 pages
http://dx.doi.org/10.1155/2012/852362
Research Article

Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus), Prevents Platelet Activation in Human Platelets

1Department of Surgery, Hsinchu Mackay Memorial Hospital, Hsinchu and Mackay Medicine, Nursing and Management College, 92 Zhong-Shan N. Road, Taipei 104, Taiwan
2Department of Pharmacology and Graduate Institute of Medical Sciences, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan
3Department of Orthopedics, Tungs’ Taichung MetroHarbor Hospital, 699 Chung-Chi Road, Taichung 435, Taiwan
4Central Laboratory, Shin-Kong Wu Ho-Su Memorial Hospital, 95 Wen-Chang Road, Taipei 111, Taiwan

Received 15 December 2011; Accepted 15 February 2012

Academic Editor: Vincenzo De Feo

Copyright © 2012 Ye-Ming Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Genkinger, E. A. Platz, S. C. Hoffman, G. W. Comstock, and K. J. Helzlsouer, “Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland,” American Journal of Epidemiology, vol. 160, no. 12, pp. 1223–1233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Zanoli and M. Zavatti, “Pharmacognostic and pharmacological profile of Humulus lupulus L,” Journal of Ethnopharmacology, vol. 116, no. 3, pp. 383–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. N. T. Xuan, E. Shumilina, E. Gulbins, S. Gu, F. Götz, and F. Lang, “Triggering of dendritic cell apoptosis by xanthohumol,” Molecular Nutrition and Food Research, vol. 54, supplement 2, pp. S214–S224, 2010. View at Publisher · View at Google Scholar
  4. C. Gerhauser, A. Alt, E. Heiss et al., “Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop,” Molecular Cancer Therapeutics, vol. 1, no. 11, pp. 959–969, 2002. View at Google Scholar · View at Scopus
  5. K. B. Harikumar, A. B. Kunnumakkara, K. S. Ahn et al., “Modification of the cysteine residues in IκBα kinase and NF-κB (p65) by xanthohumol leads to suppression of NF-κB-regulated gene products and potentiation of apoptosis in leukemia cells,” Blood, vol. 113, no. 9, pp. 2003–2013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. C. Colgate, C. L. Miranda, J. F. Stevens, T. M. Bray, and E. Ho, “Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells,” Cancer Letters, vol. 246, no. 1-2, pp. 201–209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Albini, R. Dell'Eva, R. Vené et al., “Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-κB and Akt as targets,” The FASEB Journal, vol. 20, no. 3, pp. 527–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Lupinacci, J. Meijerink, J. P. Vincken, B. Gabriele, H. Gruppen, and R. F. Witkamp, “Xanthohumol from hop (Humulus lupulus L.) Is an efficient inhibitor of monocyte chemoattractant protein-1 and tumor necrosis factor-α release in LPS-Stimulated RAW 264.7 mouse macrophages and U937 human monocytes,” Journal of Agricultural and Food Chemistry, vol. 57, no. 16, pp. 7274–7281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Dorn, B. Kraus, M. Motyl et al., “Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis,” Molecular Nutrition and Food Research, vol. 54, supplement 2, pp. S205–S213, 2010. View at Publisher · View at Google Scholar
  10. J. R. Sheu, C. R. Lee, C. H. Lin et al., “Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets,” Thrombosis and Haemostasis, vol. 83, no. 5, pp. 777–784, 2000. View at Google Scholar · View at Scopus
  11. B. Olas, J. Kolodziejczyk, B. Wachowicz, D. Jȩdrejek, A. Stochmal, and W. Oleszek, “The extract from hop cones (Humulus lupulus) as a modulator of oxidative stress in blood platelets,” Platelets, vol. 22, no. 5, pp. 345–352, 2011. View at Publisher · View at Google Scholar
  12. J. R. Sheu, W. C. Hung, C. H. Wu et al., “Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia,” Circulation, vol. 99, no. 23, pp. 3056–3062, 1999. View at Google Scholar · View at Scopus
  13. D. S. Chou, G. Hsiao, M. Y. Shen, Y. J. Tsai, T. F. Chen, and J. R. Sheu, “ESR spin trapping of a carbon-centered free radical from agonist-stimulated human platelets,” Free Radical Biology and Medicine, vol. 39, no. 2, pp. 237–248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. W. D. Singer, H. A. Brown, and P. C. Sternweis, “Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D,” Annual Review of Biochemistry, vol. 66, pp. 475–509, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. A. S. Kraft and W. B. Anderson, “Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane,” Nature, vol. 301, no. 5901, pp. 621–623, 1983. View at Google Scholar · View at Scopus
  16. J. F. Stevens and J. E. Page, “Xanthohumol and related prenylflavonoids from hops and beer: to your good health!,” Phytochemistry, vol. 65, no. 10, pp. 1317–1330, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. C. L. Miranda, J. F. Stevens, A. Helmrich et al., “Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines,” Food and Chemical Toxicology, vol. 37, no. 4, pp. 271–285, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Mangin, Y. Yuan, I. Goncalves et al., “Signaling role for phospholipase Cγ2 in platelet glycoprotein Ibα calcium flux and cytoskeletal reorganization: involvement of a pathway distinct from FcRγ chain and FcγRIIA,” Journal of Biological Chemistry, vol. 278, no. 35, pp. 32880–32891, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Pascale, M. Amadio, S. Govoni, and F. Battaini, “The aging brain, a key target for the future: the protein kinase C involvement,” Pharmacological Research, vol. 55, no. 6, pp. 560–569, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Ragab, S. Séverin, M. P. Gratacap et al., “Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLCγ2 activation,” Blood, vol. 110, no. 7, pp. 2466–2474, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Bugaud, F. Nadal-Wollbold, S. Lévy-Toledano, J. P. Rosa, and M. Bryckaert, “Regulation of c-Jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets,” Blood, vol. 94, no. 11, pp. 3800–3805, 1999. View at Google Scholar · View at Scopus
  22. P. E. Hughes, M. W. Renshaw, M. Pfaff et al., “Suppression of integrin activation: a novel function of a Ras/Raf- initiated MAP kinase pathway,” Cell, vol. 88, no. 4, pp. 521–530, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Coulon, C. Calzada, P. Moulin, E. Véricel, and M. Lagarde, “Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets,” Free Radical Biology and Medicine, vol. 35, no. 6, pp. 616–625, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Chen, S. De, D. S. Damron, W. S. Chen, N. Hay, and T. V. Byzova, “Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice,” Blood, vol. 104, no. 6, pp. 1703–1710, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Woulfe, H. Jiang, A. Morgans, R. Monks, M. Birnbaum, and L. F. Brass, “Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2,” Journal of Clinical Investigation, vol. 113, no. 3, pp. 441–450, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. T. F. Franke, S. I. Yang, T. O. Chan et al., “The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase,” Cell, vol. 81, no. 5, pp. 727–736, 1995. View at Google Scholar · View at Scopus
  27. W.-J. Lu, J.-J. Lee, D.-S. Chou et al., “A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP,” Journal of Molecular Medicine, vol. 89, no. 12, pp. 1261–1273, 2011. View at Publisher · View at Google Scholar
  28. U. Walter, M. Eigenthaler, J. Geiger, and M. Reinhard, “Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets,” Advances in Experimental Medicine and Biology, vol. 344, pp. 237–249, 1993. View at Google Scholar · View at Scopus
  29. E. Gkaliagkousi, J. Ritter, and A. Ferro, “Platelet-derived nitric oxide signaling and regulation,” Circulation Research, vol. 101, no. 7, pp. 654–662, 2007. View at Publisher · View at Google Scholar · View at Scopus